Christer Ahlberg

All filings by Christer Ahlberg on record concern Cinclus Pharma Holding AB (publ). In total, 3 filings cover trades dated from 20 June 2024 to 11 December 2025.

Every open-market trade on record is a purchase: 3 purchases worth €133k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings 1 purchase and no sales.

Half of the purchases are above €46k and half below. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -15.7%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 15 December 2025, the filings show an open-market purchase worth €46k in Cinclus Pharma Holding AB (publ). Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.